/* Contact Us page - stop contact row expanding beyond 1800px */

Dr. Neslihan Yildiz-Ozhan, a postdoctoral research fellow in the Psychiatry Neuroimaging Laboratory, received the Poster of Distinction in Psychiatry at the MGB 2026 Inaugural Celebration of Science, an honor awarded to just 16 posters from over 500 submissions. Her poster, titled “Prenatal Cannabis Exposure and Childhood Neurobehavioral Outcomes: Evidence From a Large Population-Based Cohort,” explores the potential effects of cannabis use during pregnancy on children’s neurobehavioral development.

Using data from the Adolescent Brain Cognitive Development (ABCD) study, Dr. Yildiz-Ozhan and her collaborator, Suheyla Cetin-Karayumak, Ph.D., found that children exposed to cannabis before birth showed increased behavioral challenges.

The recognition of Dr. Yildiz-Ozhan’s work highlights the growing interest in and importance of research on the developmental impacts of prenatal substance exposure, as well as the value of her research endeavors.

Congratulations to Dr. Yildiz-Ozhan on all her achievements!

For additional information about the MGB 2026 Inaugural Celebration of Science presenters, please visit their website: https://mgbresearch.org/celebration-of-science-2026/.

—

POSTER ABSTRACT

INVESTIGATORS: N. Yildiz-Ozhan, S. Cetin-Karayumak
Prenatal cannabis exposure has increased in the United States over the past decade, alongside changing cannabis policies, raising concerns about potential impacts on child neurodevelopment. Using baseline data from 7,713 children aged 9–10 years in the Adolescent Brain Cognitive Development (ABCD) Study, we examined associations between prenatal cannabis exposure and neurobehavioral outcomes in late childhood. Behavioral outcomes were assessed using the Child Behavior Checklist (CBCL), and white matter microstructure was quantified using fractional anisotropy (FA) across 73 major white matter tracts. Linear mixed-effects models were used to estimate group differences, accounting for family relatedness and adjusting for child age, sex, socioeconomic indicators, prenatal exposure to other substances, and relevant environmental covariates. Multiple comparisons across white matter tracts were controlled using the false discovery rate (FDR) method. Compared with unexposed children, those with prenatal cannabis exposure showed significantly higher behavioral problem scores, including elevated CBCL Total Problems (T-score: 54.26 ± 11.21 vs. 45.33 ± 11.80) and higher scores across multiple CBCL domains such as attention problems, social problems, and externalizing symptoms (Total Problems: β = 5.10, FDR-corrected  p < 0.001). In tract-based analyses, children with prenatal cannabis exposure showed lower FA in several fronto-parietal and fronto-temporal association pathways, including the superior longitudinal and arcuate fasciculi; however, these differences did not survive FDR correction. In this large cohort, prenatal cannabis exposure was consistently associated with higher behavioral problem burden in late childhood, underscoring the relevance of behavioral assessment for characterizing exposure-related neurodevelopmental risk.